NCP Flanders
choose your programme
Horizon Europe

Horizon Europe is the main Research and Innovation Funding Programme of the European Commission.

Horizon 2020

Horizon 2020 is the previous Funding Programme. There are no longer calls, but projects can run until 2024.

Digital Europe

Digital Europe is a Funding Programme focused on bringing digital technology to businesses, citizens and administrations.

Other EU Funding

There are many other relevant EU funding programmes, managed by several agencies and directorates.

Horizon Europe for Beginners

 Pick a topic from the menu to get started.

NCP Flanders advisors explain the basic aspects of Horizon Europe - the EU’s key funding programme for research and innovation.

The programme:

  • Introduction Horizon Europe and how to find call topics
  • How to interpret calls & how to prepare a good proposal
  • Basic principles of legal and financial issues
  • Service of NCP and Enterprise Europe Network (E.E.N.)

Target audience: every stakeholder in Flanders interested as well from private companies as from research and higher educations institutes, governmental services and non-profit organisations, who has limited experience with Horizon 2020/Europe.

 Pick a topic from the menu to get started.

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.